Informations générales (source: ClinicalTrials.gov)
Creation of a Cohort for the Quantitation and Characterization of Circulating Viral RNAs as a New Biomarker of Hepatitis B Functional Cure. (CirB-RNA)
Observational
Hospices Civils de Lyon (Voir sur ClinicalTrials)
février 2019
juin 2029
29 juin 2024
The " CirB-RNA " cohort aims to create a biological collection associated with clinical
and biological data from patients with hepatitis B infection. This project is part of a
much larger program that aims to characterize and quantify circulating viral RNAs as a
possible new biomarker of hepatitis B functional cure.
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| Hepatology department - Groupement Hospitalier Nord - Hôpital de la Croix-Rousse - 69004 - Lyon - France | Fabien ZOULIM, Pr | Contact (sur clinicalTrials) | |||
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| Department of Hepato-gastroenterology and pediatric nutrition - Hôpital Femme-Mère Enfant - 69677 - Lyon - France | Noémie Laverdure, MD, PhD | Contact (sur clinicalTrials) | |||
| Hôpital de la Croix-Rousse - Service de maladies infectieuses et tropicales - 69317 - Lyon - France | Patrick MIAILHES, MD, PhD | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- Adults patients and minor children over 6 years of age (in Lyon) with acute or
chronic hepatitis B or presenting with HBsAg loss (with/without HBs seroconversion).
(Co-infected patients with HDV and/or HCV and/or HIV are eligible)
- Patients requiring blood sampling for medical care at the time of the medical
appointment.
- Informed patients who do not refuse to participate.
- Persons not affiliated to a social security scheme and persons receiving medical
assistance from the state may be asked to participate in the study
- Adults patients and minor children over 6 years of age (in Lyon) with acute or
chronic hepatitis B or presenting with HBsAg loss (with/without HBs seroconversion).
(Co-infected patients with HDV and/or HCV and/or HIV are eligible)
- Patients requiring blood sampling for medical care at the time of the medical
appointment.
- Informed patients who do not refuse to participate.
- Persons not affiliated to a social security scheme and persons receiving medical
assistance from the state may be asked to participate in the study
- Patients participating at the time of the inclusion to an interventional trial
evaluating a drug likely to interfere with this study.
- Persons deprived of their liberty by a judicial or administrative decision
- Adults who are subject to a legal protection measure
- Children less than 6 years old (in Lyon)